Here, we detected protein expression of IgG and IgM on the cell membrane of CD33+ myeloblasts (CD19−CD33+ CD138−) from AML patients by flow cytometry, with B cells (CD19+SSClow) as the control (Figure 2A). Here, CD33 is linked to acute myeloid leukemia.